NLRP3 and synovial sarcoma: Such is the case of MALT lymphoma development in the setting of autoimmunity, where NLRP3 inflammasome activation was mainly investigated in the setting of SS, an autoimmune disease correlating with lymphomagenesis due to chronic antigenic stimulation [225].